JP2001002574A - Accelerator for recovering skin barrier function - Google Patents

Accelerator for recovering skin barrier function

Info

Publication number
JP2001002574A
JP2001002574A JP17131799A JP17131799A JP2001002574A JP 2001002574 A JP2001002574 A JP 2001002574A JP 17131799 A JP17131799 A JP 17131799A JP 17131799 A JP17131799 A JP 17131799A JP 2001002574 A JP2001002574 A JP 2001002574A
Authority
JP
Japan
Prior art keywords
barrier function
skin barrier
skin
tewl
phytosterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP17131799A
Other languages
Japanese (ja)
Inventor
Mototsugu Takahashi
元次 高橋
Tetsuji Hirao
哲二 平尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP17131799A priority Critical patent/JP2001002574A/en
Publication of JP2001002574A publication Critical patent/JP2001002574A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject accelerator capable of recovering reduced skin barrier function remarkably in a short time by containing phytosterol. SOLUTION: This accelertor for recovering skin barrier function contains phytosterol. Phytosterol is a mixture of plant originated sterols and mainly contains β-sitosterol, campesterol, stigmasterol, etc. To accelerate recovering of skin barrier function means to have an accelerating effect in a TEWL recovery factor with a clearly significant difference when TEWL values at every measuring time are compared with the value without any treatment by bringing the TEWL value after 1 hour of tape stripping of the skin to be 0% and the value before the tape stripping to be 100%. The accelerator can be added to cosmetics, medicines and quasi-drug baes. The amount to be added is preferably 0.1-20 wt.% in the whole amount of the aforesaid cosmetic and the like.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は皮膚バリアー機能回
復促進剤に関する。さらに詳しくは、皮膚バリアー機能
の回復を促進して、皮膚の表皮機能の低下による表皮増
殖性異常等を防止するために有用な皮膚バリアー機能回
復促進剤に関する。
The present invention relates to an agent for promoting the recovery of skin barrier function. More specifically, the present invention relates to a skin barrier function recovery promoter useful for promoting recovery of skin barrier function and preventing epidermal hyperplasia due to a decrease in skin epidermal function.

【0002】[0002]

【従来の技術】種々の皮膚疾患等に見られる肌荒れ症状
においては、皮膚からの水分の消失が、健常な皮膚に比
べて盛んであることが知られている。このいわゆる経皮
水分蒸散量(以下、TEWLともいう)の増加には、表
皮内において水分の保持やバリアーとしての機能を担っ
ていると考えられる成分の減少が関与しているものと考
えられてきた。
2. Description of the Related Art It is known that in skin roughening symptoms seen in various skin diseases and the like, the loss of moisture from the skin is more active than in healthy skin. It has been considered that the increase in the so-called transdermal water loss (hereinafter also referred to as TEWL) involves the reduction of components that are considered to be responsible for water retention and barrier function in the epidermis. Was.

【0003】したがって、従来より、皮膚疾患や肌荒れ
に対して改善・予防効果を有する有効成分として、水分
保持機能や皮膚バリアー機能を担う表皮内成分を皮膚に
補充するという観点から、NMF(Natural Moisturizi
ng Factor)としてのアミノ酸や、角質細胞間脂質とし
ての脂質類、その他ヒアルロン酸等のムコ多糖あるいは
これらの類似物質が、安全性も高いことから、化粧料や
皮膚外用剤に配合されている。
Therefore, NMF (Natural Moisturizi) has been conventionally used as an active ingredient having an effect of improving and preventing skin diseases and rough skin from the viewpoint of replenishing the skin with an intra-epidermal component having a moisture retaining function and a skin barrier function.
Amino acids as ng Factor), lipids as keratinocyte intercellular lipids, and other mucopolysaccharides such as hyaluronic acid or similar substances have been added to cosmetics and external preparations for skin because of their high safety.

【0004】また、最近では、皮膚バリアー機能を担う
表皮内成分の生合成を活性化させるような特定の物質
が、肌荒れに対して改善効果を有するという報告がなさ
れている(特開平9−2952号公報)。
[0004] Recently, it has been reported that a specific substance that activates the biosynthesis of an intraepidermal component that is responsible for the skin barrier function has an effect of improving skin roughness (Japanese Patent Laid-Open No. 9-2952). No.).

【0005】[0005]

【発明が解決しようとする課題】しかしながら、肌荒れ
改善・予防効果を有する物質については多くの研究がな
されてきたが、皮膚バリアー機能の改善若しくは回復効
果を有する物質についての研究は十分ではなく、皮膚バ
リアー機能に対する改善効果と肌荒れ改善・予防効果と
の関係は明らかになっていないため、肌荒れ改善・予防
効果がある物質が必ずしも皮膚バリアー機能に対する改
善効果があるとは限らない。
However, although many studies have been made on substances having an effect of improving and preventing rough skin, studies on substances having an effect of improving or recovering the skin barrier function are not sufficient. Since the relationship between the effect of improving the barrier function and the effect of improving and preventing rough skin is not clear, a substance having the effect of improving and preventing rough skin does not necessarily have the effect of improving the skin barrier function.

【0006】一方、皮膚バリアー機能が低下すると、皮
膚の表皮機能が低下し、表皮増殖性異常等が起こること
が報告されている。特に、高齢者の場合は、低下した皮
膚バリアー機能の回復には長い時間がかかり、加齢に伴
う皮膚の表皮機能の低下による表皮増殖性異常等を防止
するために有効な新規の皮膚バリアー機能回復促進剤に
開発が要望されていた。
[0006] On the other hand, it has been reported that when the skin barrier function is reduced, the epidermal function of the skin is reduced and abnormal epidermal proliferation is caused. In particular, in the case of elderly people, it takes a long time to recover the reduced skin barrier function, and a new skin barrier function that is effective to prevent epidermal hyperproliferative abnormalities due to a decrease in skin epidermal function with aging The development of a recovery accelerator was requested.

【0007】本発明者らは、上記事情に鑑み、皮膚バリ
アー機能の低下、すなわち、TEWLの変化に対して敏
速に作用する物質について広く研究した結果、フィトス
テロールがダメージを受けた皮膚バリアー機能を極めて
短時間のうちに回復させるという新たな知見を見出し本
発明を完成するに至った。
[0007] In view of the above circumstances, the present inventors have conducted extensive research on substances having a reduced skin barrier function, that is, substances which act rapidly on changes in TEWL. The present inventors have found a new finding of recovery within a short time and have completed the present invention.

【0008】本発明は低下した皮膚バリアー機能を極め
て短時間のうちに回復させることができる新規な皮膚バ
リアー機能回復促進剤を提供することを目的とする。
[0008] It is an object of the present invention to provide a novel skin barrier function recovery promoter capable of recovering a reduced skin barrier function in an extremely short time.

【0009】[0009]

【課題を解決するための手段】すなわち、本発明は、フ
ィトステロールからなることを特徴とする皮膚バリアー
機能回復促進剤を提供するものである。
That is, the present invention provides a skin barrier function recovery promoting agent comprising phytosterol.

【0010】[0010]

【発明の実施の形態】以下、本発明の構成について詳述
する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The configuration of the present invention will be described below in detail.

【0011】本発明に用いるフィトステロールは植物由
来のステロールの混合物で、主成分としてβ−シトステ
ロール、カンペステロール、スティグマステロールなど
を含み、皮膚外用剤あるいは化粧料の配合成分として従
来公知の物質であるが、皮膚バリアー機能の回復を促進
する効果を有するという報告はこれまでになく、本発明
者らによって初めて見出された効果である。
The phytosterol used in the present invention is a mixture of plant-derived sterols, which contains β-sitosterol, campesterol, stigmasterol and the like as main components, and is a substance which is conventionally known as a component of a skin external preparation or cosmetic. It has never been reported that it has an effect of promoting the recovery of the skin barrier function, and this is the first effect found by the present inventors.

【0012】本発明において、皮膚バリアー機能の回復
を促進するとは、詳細は後述するが、皮膚をテープスト
リッピング1時間後のTEWLの値を0%、テープスト
リッピング前の値を100%として、各測定時間におけ
るTEWLの値が、何も塗布しない状態と比較した場合
に明らかに有意差が認められ、TEWL回復率を促進さ
せる効果を有することを意味し、Andrewらの方法
(J Invest Dermatol,86;598,1986)に従って、4%の
ドデシル硫酸ナトリウム(SDS)水溶液をしみ込ませ
たCotton ballにより皮膚を処理して判定を行ういわゆ
る肌荒れ改善防止効果とは異なる。
In the present invention, promoting the recovery of the skin barrier function is described in detail later. Each measurement was performed by setting the TEWL value of the skin 1 hour after tape stripping to 0% and the value before tape stripping to 100%. The value of TEWL at time showed a significant difference when compared to the state where nothing was applied, meaning that it had an effect of promoting the recovery rate of TEWL, and the method of Andrew et al. (J Invest Dermatol, 86; 598, 1986), which is different from the so-called skin roughness improvement prevention effect in which skin is treated with a Cotton ball impregnated with a 4% aqueous solution of sodium dodecyl sulfate (SDS) to make a judgment.

【0013】本発明の皮膚バリアー機能回復促進剤は、
化粧料、医薬品、医薬部外品用基剤に配合されて、例え
ば、軟膏、クリーム、乳液、ローション、パック、浴用
剤等の化粧料、医薬品、医薬部外品として皮膚に適用す
ることが出来る。配合量は特に制限がないが、上記化粧
料等全量中、好ましくは0.1〜20重量%である。
The skin barrier function recovery promoter of the present invention comprises:
It can be applied to the skin as a cosmetic, pharmaceutical, quasi-drug, for example, as a cosmetic, pharmaceutical, quasi-drug base, for example, ointment, cream, emulsion, lotion, pack, bath agent, etc. . The amount is not particularly limited, but is preferably 0.1 to 20% by weight based on the total amount of the cosmetics and the like.

【0014】[0014]

【実施例】次に、本発明を実施例を挙げてさらに詳細に
説明するが、本発明の技術的範囲がこれらの実施例に限
定されるものではない。配合量は重量%である。
Next, the present invention will be described in more detail with reference to examples, but the technical scope of the present invention is not limited to these examples. The compounding amount is% by weight.

【0015】皮膚バリアー機能の回復促進効果を以下の
方法で評価し、その結果を図1に示した。
The effect of promoting the recovery of the skin barrier function was evaluated by the following method, and the results are shown in FIG.

【0016】「皮膚バリアー機能回復促進効果試験」皮
膚をテープストリッピングすることによって破壊された
皮膚バリアー機能が、もとの状態へ回復していく過程に
おけるフィトステロール含有試料の影響を、TEWLを
指標として以下の方法で評価した。すなわち、10名の
男性パネルの前腕内側部を対象として実験を行った。T
EWLはTEWAMETER TM-200(COURAGE+KHAZAKA)にて測定
した。予め、対象部位のTEWLを測定した後、セロハ
ンテープを貼り、直ちにはがし、この操作を10回繰り
返した。この操作の1時間後に当該部位のTEWLを測
定した。プロピレングリコール:エタノール=7:3の
基剤に、フィトステロールを2重量%になるように配合
した試料を6cmあたり50μlになるように塗布し
た。また、対照として、同様にテープストリッピングを
施した部位に前記基剤のみを塗布した。試料塗布の3時
間後にTEWLを再度測定した。テープストリッピング
前のTEWLを0%、テープストリッピング1時間後の
試料塗布前のTEWLを100%として、3時間後のT
EWL測定値の相対値を算出し、回復促進効果を評価し
た。10名の平均値を算出し、フィトステロール塗布群
と基剤のみ塗布群とを比較した結果を、図1に示す。
"Skin Barrier Function Recovery Acceleration Effect Test" The effect of a phytosterol-containing sample on the process in which the skin barrier function destroyed by stripping the skin to the original state is restored using TEWL as an index. Was evaluated. That is, the experiment was performed on the inner part of the forearm of 10 male panels. T
EWL was measured with TEWAMETER TM-200 (COURAGE + KHAZAKA). After measuring the TEWL of the target site in advance, a cellophane tape was applied, immediately peeled off, and this operation was repeated 10 times. One hour after this operation, the TEWL of the site was measured. A sample in which phytosterol was blended at a ratio of 2% by weight to a base of propylene glycol: ethanol = 7: 3 was applied so as to be 50 μl per 6 cm 2 . In addition, as a control, only the above-mentioned base was applied to the site where tape stripping was performed in the same manner. TEWL was measured again 3 hours after sample application. The TEWL before 3 hours after the tape stripping is 0%, and the TEWL before the sample application 1 hour after the tape stripping is 100%.
The relative value of the EWL measurement value was calculated, and the recovery promoting effect was evaluated. FIG. 1 shows the results of calculating the average value of 10 subjects and comparing the phytosterol application group with the base application only group.

【0017】本評価法ではTEWL相対値が0%になる
ことは完全に回復したことを意味する。したがって、フ
ィトステロール含有試料は、対照である基剤に比較して
TEWLの回復を有意に促進したと判断される。
In this evaluation method, a TEWL relative value of 0% means that the TEWL is completely recovered. Therefore, it is judged that the phytosterol-containing sample significantly accelerated the recovery of TEWL as compared to the control base.

【0018】以下に、本発明の皮膚バリアー機能回復促
進剤の配合例を挙げる。
Examples of the formulation of the skin barrier function recovery promoter of the present invention are described below.

【0019】「クリーム」 (処方) 重量% 固形パラフィン 5.0 ミツロウ 10.0 ワセリン 15.0 流動パラフィン 41.0 グリセリンモノステアリン酸エステル 2.0 ポリオキシエチレン(20モル) ソルビタンモノラウリル酸エステル 2.2 石鹸粉末 0.1 硼砂 0.2 フィトステロール 1.0 亜硫酸水素ナトリウム 0.03 エチルパラベン 0.3 香料 適量 イオン交換水 残余 (製法)イオン交換水にフィトステロール、石鹸粉末、
硼砂を加え、加熱して70℃に保った(水相)。また、
他の成分を混合し加熱融解して70℃に保った(油
相)。水相に油相を攪拌しながら徐々に加え、全部加え
終わってからしばらくその温度に保ち反応を起こさせ
た。その後、ホモミキサーで均一に乳化し、よくかきま
ぜながら30℃まで冷却し、クリームを得た。
"Cream" (formulation)% by weight Solid paraffin 5.0 Beeswax 10.0 Vaseline 15.0 Liquid paraffin 41.0 Glycerin monostearate 2.0 Polyoxyethylene (20 mol) Sorbitan monolaurate 2 0.2 Soap powder 0.1 Borax 0.2 Phytosterol 1.0 Sodium bisulfite 0.03 Ethylparaben 0.3 Perfume Appropriate amount Ion-exchange water Residue (Production method) Phytosterol, soap powder,
Borax was added and heated to 70 ° C. (aqueous phase). Also,
The other components were mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase was gradually added to the aqueous phase with stirring, and after the addition was completed, the temperature was maintained for a while to cause a reaction. Thereafter, the mixture was uniformly emulsified with a homomixer and cooled to 30 ° C. while stirring well to obtain a cream.

【0020】「ゼリー」 (処方) 重量% 95%エタノール 10.0 ジプロピレングリコール 15.0 ポリオキシエチレン(50モル) オレイルアルコールエーテル 3.0 カルボキシビニルポリマー 0.05 (商品名:カーボポール940,B.F.Goodrich Chemical co
mpany) 水酸化ナトリウム 0.15 フィトステロール 1.0 亜硫酸水素ナトリウム 0.01 エチルパラベン 0.3 香料 適量 イオン交換水 残余 (製法)イオン交換水にカルボキシビニルポリマーを均
一に溶解し、ポリオキシエチレン(50モル)オレイル
アルコールエーテルを水相に添加した。次いで、その他
の成分を加えた後、水酸化ナトリウム、フィトステロー
ルで中和させ増粘し、ゼリーを得た。
"Jelly" (formulation) weight% 95% ethanol 10.0 dipropylene glycol 15.0 polyoxyethylene (50 mol) oleyl alcohol ether 3.0 carboxyvinyl polymer 0.05 (trade name: Carbopol 940, BFGoodrich Chemical co
mpany) Sodium hydroxide 0.15 Phytosterol 1.0 Sodium bisulfite 0.01 Ethyl paraben 0.3 Perfume Appropriate amount Ion-exchange water Residue (Preparation method) Carboxyvinyl polymer is uniformly dissolved in ion-exchange water, and polyoxyethylene (50 Mol) oleyl alcohol ether was added to the aqueous phase. Next, after adding other components, the mixture was neutralized with sodium hydroxide and phytosterol to increase the viscosity, thereby obtaining a jelly.

【0021】「パック」 (処方) 重量% (A相) ジプロピレングリコール 5.0 ポリオキシエチレン(60モル) 硬化ヒマシ油 5.0 フィトステロール 1.0 (B相) オリーブ油 5.0 酢酸トコフェロール 0.2 エチルパラベン 0.2 香料 0.2 (C相) 亜硫酸水素ナトリウム 0.03 ポリビニルアルコール 13.0 (けん化度90、重合度2000) エタノール 7.0 イオン交換水 残余 (製法)A相、B相、C相をそれぞれ均一に溶解し、A
相にB相を加えて可溶化した。次いで、これにC相を加
えた後、充填を行い、パックを得た。
"Pack" (formulation)% by weight (phase A) dipropylene glycol 5.0 polyoxyethylene (60 mol) hydrogenated castor oil 5.0 phytosterol 1.0 (phase B) olive oil 5.0 tocopherol acetate 0. 2 Ethylparaben 0.2 Fragrance 0.2 (Phase C) Sodium bisulfite 0.03 Polyvinyl alcohol 13.0 (Saponification degree 90, Polymerization degree 2000) Ethanol 7.0 Deionized water Residue (Production method) A phase, B phase , C phase are uniformly dissolved,
Phase B was added to solubilize. Next, after adding the phase C to this, filling was performed to obtain a pack.

【0022】[0022]

【発明の効果】本発明によれば、皮膚のバリアー機能の
回復を促進出来る優れた皮膚バリアー機能回復促進剤を
提供できる。
According to the present invention, it is possible to provide an excellent skin barrier function recovery promoter which can promote the recovery of skin barrier function.

【図面の簡単な説明】[Brief description of the drawings]

【図1】フィトステロールの皮膚バリアー機能回復促進
効果をTEWLを指標として評価したグラフである。
FIG. 1 is a graph showing the effect of promoting the recovery of phytosterol on the skin barrier function evaluated using TEWL as an index.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA082 AA122 AB032 AB272 AB352 AC012 AC022 AC102 AC122 AC182 AC242 AC422 AC432 AC442 AC482 AD092 AD112 AD491 AD492 AD662 CC02 CC05 CC07 EE12 4C086 AA01 AA02 DA11 MA04 NA14 ZA89  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AA082 AA122 AB032 AB272 AB352 AC012 AC022 AC102 AC122 AC182 AC242 AC422 AC432 AC442 AC482 AD092 AD112 AD491 AD492 AD662 CC02 CC05 CC07 EE12 4C086 AA01 AA02 DA11 MA04 NA14 ZA89

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 フィトステロールからなることを特徴と
する皮膚バリアー機能回復促進剤。
1. A skin barrier function recovery promoter comprising phytosterol.
JP17131799A 1999-06-17 1999-06-17 Accelerator for recovering skin barrier function Withdrawn JP2001002574A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17131799A JP2001002574A (en) 1999-06-17 1999-06-17 Accelerator for recovering skin barrier function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17131799A JP2001002574A (en) 1999-06-17 1999-06-17 Accelerator for recovering skin barrier function

Publications (1)

Publication Number Publication Date
JP2001002574A true JP2001002574A (en) 2001-01-09

Family

ID=15921016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17131799A Withdrawn JP2001002574A (en) 1999-06-17 1999-06-17 Accelerator for recovering skin barrier function

Country Status (1)

Country Link
JP (1) JP2001002574A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020063987A (en) * 2001-01-31 2002-08-07 나드리화장품주식회사 Cosmetic composition having anti-irritation effect
JP2003026535A (en) * 2001-07-17 2003-01-29 Tsumura & Co Agent for inhibiting disorder of epidermis barrier function
JP2005002063A (en) * 2003-06-13 2005-01-06 Shiseido Co Ltd Agent for promoting recovery of barrier function of skin
JP2006199678A (en) * 2004-12-24 2006-08-03 Maruzen Pharmaceut Co Ltd Skin cosmetic and food/drink for cosmetrogical use
KR100777554B1 (en) * 2001-11-08 2007-11-16 주식회사 엘지생활건강 Composition for skin whitening containing Sitosterol
JP2009256252A (en) * 2008-04-17 2009-11-05 Pola Chem Ind Inc Detergent
JP2015189723A (en) * 2014-03-28 2015-11-02 小林製薬株式会社 Ceramide-containing external preparation composition
JP2017105741A (en) * 2015-12-12 2017-06-15 オリザ油化株式会社 Promotor for production of glucosylceramide and expression of metabolism gene in skin
WO2024075548A1 (en) * 2022-10-07 2024-04-11 株式会社 資生堂 Gel composition and oil-in-water-type composition

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020063987A (en) * 2001-01-31 2002-08-07 나드리화장품주식회사 Cosmetic composition having anti-irritation effect
JP2003026535A (en) * 2001-07-17 2003-01-29 Tsumura & Co Agent for inhibiting disorder of epidermis barrier function
KR100777554B1 (en) * 2001-11-08 2007-11-16 주식회사 엘지생활건강 Composition for skin whitening containing Sitosterol
JP2005002063A (en) * 2003-06-13 2005-01-06 Shiseido Co Ltd Agent for promoting recovery of barrier function of skin
JP2006199678A (en) * 2004-12-24 2006-08-03 Maruzen Pharmaceut Co Ltd Skin cosmetic and food/drink for cosmetrogical use
JP2009256252A (en) * 2008-04-17 2009-11-05 Pola Chem Ind Inc Detergent
JP2015189723A (en) * 2014-03-28 2015-11-02 小林製薬株式会社 Ceramide-containing external preparation composition
JP2017105741A (en) * 2015-12-12 2017-06-15 オリザ油化株式会社 Promotor for production of glucosylceramide and expression of metabolism gene in skin
WO2024075548A1 (en) * 2022-10-07 2024-04-11 株式会社 資生堂 Gel composition and oil-in-water-type composition

Similar Documents

Publication Publication Date Title
EP1339413B1 (en) Compositions comprising complexes of phosphate derivatives of tocopherol
EP0336902A2 (en) Antiinflammatory skin moisturizing composition and method of preparing same
KR20090079266A (en) Pharmaceutical composition
JP2001002574A (en) Accelerator for recovering skin barrier function
JP2003128531A (en) Dermal external agent
JP2000290135A (en) Agent for promoting restoration of skin barrier function
JP2002161027A (en) Method for suppressing inflammation and erythema and composition therefor
AU769079B2 (en) Topical formulations comprising skin penetration agents and the use thereof
JPH1017461A (en) Preparation for external use for improving skin roughness
WO2008013669A2 (en) Alpha hydroxy acid sustained release formulation
JP2000103728A (en) Skin barrier function recovery promoter
CN112656695A (en) Preparation of retinol nano-emulsion with low irritation and high stability
JPH11269034A (en) Skin prepafation for external use for improving acne
JP2006298796A (en) External preparation for improving fine wrinkle
JP3104938B2 (en) Cosmetics
JP5670008B2 (en) Adapalene-containing external preparation composition
JPH11322575A (en) Skin preparation for external use for improving and preventing skin roughening
JP5109383B2 (en) Adapalene-containing external preparation composition
US20030152599A1 (en) Composition for external use
JP2002012512A (en) Composition for external use
JP3333428B2 (en) External preparation for skin
JPH0692833A (en) Skin external agent
JPH10120521A (en) Translucent cosmetic
JP2522803B2 (en) Cosmetics
JP2002302448A (en) Skin care preparation

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060905